CClinicalTrials.gg
CompletedNCT00472511Updated Jul 3, 2008

Study of Eyes and Attention Deficit (SEAD)

An observational study in ADHD, Convergence Insufficiency and Accommodative Insufficiency, sponsored by Ohio State University. Completed. Open to participants aged 7 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2008-07-03.

Sponsored by Ohio State University · Observational

Study type
Observational
Time perspective
Prospective
Enrollment
75
Ages
7 Years to 18 Years
Sex
All
01

Study summary

Attention-Deficit Hyperactivity Disorder (ADHD) is considered to be one of the most prevalent chronic health conditions in children. It affects between 4% and 12% of young children. A relationship between convergence insufficiency (eye teaming) and ADHD has been shown. However, the effect of ADHD medications on focusing and eye teaming has not been previously investigated. Therefore, the purpose of this study is to determine the effect of ADHD medication on focusing and eye teaming skills.

02

Conditions studied

  • ADHD
  • Convergence Insufficiency
  • Accommodative Insufficiency
03

In context

Ocular Motility Disorders

54 studies on the registry are indexed under Ocular Motility Disorders; 19 are open to participants now.

This study's enrollment of 75 is below the median of 199 across 16 observational studies indexed under Ocular Motility Disorders.

Browse Ocular Motility Disorders studies →

Lead sponsor

Ohio State University is the lead sponsor of 640 studies on the registry; 144 are open to participants now.

Of its 60 completed or terminated interventional studies of FDA-regulated products, 45 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Best corrected visual acuity of 20/25 in both eyes at distance and near;
  • Willingness to wear eyeglasses or contact lenses to correct refractive error, if necessary;
  • 500" random dot stereopsis

Exclusion criteria

Exclusion Criteria:

  • Amblyopia (lazy eye);
  • Eye disease
05

Study design

Time perspective
Prospective
Enrollment
75 participants
06

Study locations

No study locations are listed for this record.

07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 3, 2008, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00472511
Lead sponsor
Ohio State University
First posted
May 11, 2007
Last update
Jul 3, 2008

Study contacts

Levelle Jenkins, OD
principal investigator · Ohio State University
Marjean Kulp, OD, MS
principal investigator · Ohio State University
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion